We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
143 hedge funds and large institutions have $102M invested in Fate Therapeutics in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
129% more call options, than puts
Call options by funds: $112K | Put options by funds: $49K
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
16% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 38
14% more capital invested
Capital invested by funds: $88.9M → $102M (+$12.6M)
3% more funds holding
Funds holding: 139 → 143 (+4)
0.37% more ownership
Funds ownership: 69.51% → 69.87% (+0.37%)
Holders
143
Holders Change
+4
Holders Change %
+2.88%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
23
Increased
44
Reduced
38
Closed
17
Calls
$112K
Puts
$49K
Net Calls
+$63K
Net Calls Change
-$161K
Top Buyers
| 1 |
WA
Wilshire Advisors
Santa Monica,
California
|
+$9.15M |
| 2 |
Renaissance Technologies
New York
|
+$1.13M |
| 3 |
Two Sigma Investments
New York
|
+$725K |
| 4 |
Two Sigma Advisers
New York
|
+$555K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$413K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.01M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$2.78M |
| 3 |
Citigroup
New York
|
-$2.04M |
| 4 |
Morgan Stanley
New York
|
-$1.62M |
| 5 |
Goldman Sachs
New York
|
-$1.11M |
